VERTIGOHEEL - ambergris, anamirta cocculus seed, conium maculatum flowering top and kerosene tablet 
Heel Inc

Disclaimer: This homeopathic product has not been evaluated by the Food and Drug Administration for safety or efficacy. FDA is not aware of scientific evidence to support homeopathy as effective.

----------

Vertigoheel Rx Tablet

DESCRIPTION

Each 300mg tablet contains:

Active Ingredients
Ingredient namePotencyQuantityFinal dilution

Ambra grisea

6X30 mg7.00X

Cocculus indicus

4X210 mg4.15X

Conium maculatum

3X30 mg3.99X

Petroleum

8X30 mg8.99X

Inactive Ingredients

Lactose Diluent for homeopathic dilutions

Magnesium stearate  1%

INDICATION AND USAGE

Vertigoheel® Tablets are a homeopathic drug product indicated for the treatment of vertigo/dizziness of various origins; mild cognitive impairment (MCI) such as lack of concentration and forgetfulness.

DOSAGE AND ADMINISTRATION

General Considerations

• The dosage schedules listed below can be used as a general guide for the administration of Vertigoheel® Tablets.

• Allow tablets to dissolve completely in the mouth, do not swallow.

Standard Dosage:

Adults and children 12 years and older: 3 tablets per day, taking 1 tablet every 4 to 6 hours.

Acute Dosage:

Adults and children 12 years and older: 1 tablet every ½ to 1 hour until symptoms lessen, then continue with standard dosage. Do not exceed 12 tablets in 24 hours.

CONTRAINDICATIONS

  • Vertigoheel® Tablets are contraindicated in patients with known hypersensitivity to Vertigoheel® or any of its ingredients.
  • Do not use during pregnancy or breastfeeding.

WARNINGS AND PRECAUTIONS

Keep out of reach of children.

ADVERSE REACTIONS

Post-marketing Experience

• The following adverse events have been identified during post-marketing use of Vertigoheel® Tablets. Because these events are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

• Allergic (hypersensitivity) skin reactions may occur in isolated cases.

To report SUSPECTED ADVERSE REACTIONS, contact Heel Inc. at 1.800.920.9203

info@heelusa.com or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

OVERDOSAGE

No negative effects of an overdose have been reported and none are expected due to the homeopathic dilutions.

CLINICAL PHARMACOLOGY

Mechanism of Action

The exact mechanism of Vertigoheel® Tablets is not fully understood.

Pharmacodynamics

Not applicable for homeopathic medicinal products.

DOSAGE

300 mg tablets each containing the active ingredients in the strengths listed under Description.

Vertigoheel Tablet Carton v.2.jpg

VERTIGOHEEL 
ambergris, anamirta cocculus seed, conium maculatum flowering top and kerosene tablet
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:50114-6155
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
AMBERGRIS (AMBERGRIS) AMBERGRIS6 [hp_X]
ANAMIRTA COCCULUS SEED (ANAMIRTA COCCULUS SEED) ANAMIRTA COCCULUS SEED4 [hp_X]
CONIUM MACULATUM FLOWERING TOP (CONIUM MACULATUM FLOWERING TOP) CONIUM MACULATUM FLOWERING TOP3 [hp_X]
KEROSENE (KEROSENE) KEROSENE8 [hp_X]
Inactive Ingredients
Ingredient NameStrength
LACTOSE 
MAGNESIUM STEARATE 
Product Characteristics
ColorwhiteScoreno score
ShapeROUNDSize9mm
FlavorImprint Code Heel
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:50114-6155-21 in 1 CARTON
1100 in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved homeopathic01/31/198408/20/2014
Labeler - Heel Inc (102783016)
Establishment
NameAddressID/FEIBusiness Operations
Heel Inc102783016manufacture(50114-6155)

Revised: 8/2014
 
Heel Inc